BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 36853169)

  • 21. Peritumoral Immune-suppressive Mechanisms Impede Intratumoral Lymphocyte Infiltration into Colorectal Cancer Liver versus Lung Metastases.
    Ye J; Guo W; Wang C; Egelston CA; D'Apuzzo M; Shankar G; Fakih MG; Lee PP
    Cancer Res Commun; 2023 Oct; 3(10):2082-2095. PubMed ID: 37768208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic Value of the Tumor Immune Microenvironment for Early-stage, Non-Small Cell Lung Cancer.
    Tuminello S; Petralia F; Veluswamy R; Wang P; Flores R; Taioli E
    Am J Clin Oncol; 2021 Jul; 44(7):350-355. PubMed ID: 34008498
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Germinal center reactions in tertiary lymphoid structures associate with neoantigen burden, humoral immunity and long-term survivorship in pancreatic cancer.
    J Gunderson A; Rajamanickam V; Bui C; Bernard B; Pucilowska J; Ballesteros-Merino C; Schmidt M; McCarty K; Philips M; Piening B; Dubay C; Medler T; Newell P; Hansen P; Tran E; Tang E; Bifulco C; Crittenden M; Gough M; Young KH
    Oncoimmunology; 2021 Mar; 10(1):1900635. PubMed ID: 33796412
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tertiary lymphoid structures improve immunotherapy and survival in melanoma.
    Cabrita R; Lauss M; Sanna A; Donia M; Skaarup Larsen M; Mitra S; Johansson I; Phung B; Harbst K; Vallon-Christersson J; van Schoiack A; Lövgren K; Warren S; Jirström K; Olsson H; Pietras K; Ingvar C; Isaksson K; Schadendorf D; Schmidt H; Bastholt L; Carneiro A; Wargo JA; Svane IM; Jönsson G
    Nature; 2020 Jan; 577(7791):561-565. PubMed ID: 31942071
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinicopathological significance of peritumoral alveolar macrophages in patients with resected early-stage lung squamous cell carcinoma.
    Tanaka Y; Nakai T; Suzuki A; Kagawa Y; Noritake O; Taki T; Hashimoto H; Sakai T; Shibata Y; Izumi H; Nosaki K; Udagawa H; Zenke Y; Matsumoto S; Yoh K; Miyazaki S; Sakamoto N; Sakashita S; Kojima M; Watanbe R; Tsuboi M; Goto K; Ishii G
    Cancer Immunol Immunother; 2023 Jul; 72(7):2205-2215. PubMed ID: 36862151
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrative analysis of tertiary lymphoid structures and immune microenvironment in patients with esophageal carcinoma.
    Yao Y; Xuan H; Wang J; Gong L; Gao W
    Tumori; 2023 Oct; 109(5):466-480. PubMed ID: 37249074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Immunosuppressive Niche of Soft-Tissue Sarcomas is Sustained by Tumor-Associated Macrophages and Characterized by Intratumoral Tertiary Lymphoid Structures.
    Chen L; Oke T; Siegel N; Cojocaru G; Tam AJ; Blosser RL; Swailes J; Ligon JA; Lebid A; Morris C; Levin A; Rhee DS; Johnston FM; Greer JB; Meyer CF; Ladle BH; Thompson ED; Montgomery EA; Choi W; McConkey DJ; Anders RA; Pardoll DM; Llosa NJ
    Clin Cancer Res; 2020 Aug; 26(15):4018-4030. PubMed ID: 32332015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lymphocyte-activation gene 3 in non-small-cell lung carcinomas: correlations with clinicopathologic features and prognostic significance.
    Shepherd DJ; Tabb ES; Kunitoki K; Zhang ML; Kem M; Barth J; Qualls DA; Mooradian MJ; Gainor JF; Mino-Kenudson M; Hung YP
    Mod Pathol; 2022 May; 35(5):615-624. PubMed ID: 34880448
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tertiary Lymphoid Structures, Immune Response, and Prognostic Relevance in Non-Small Cell Lung Cancer.
    Giatromanolaki A; Chatzipantelis P; Contrafouris CA; Koukourakis MI
    Cancer Invest; 2023 Jan; 41(1):48-57. PubMed ID: 36239379
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tertiary Lymphoid Structure Raises Survival and Immunotherapy in HPV
    Li H; Zhu SW; Zhou JJ; Chen DR; Liu J; Wu ZZ; Wang WY; Zhang MJ; Sun ZJ
    J Dent Res; 2023 Jun; 102(6):678-688. PubMed ID: 36883630
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Profiling Tumor Immune Microenvironment of Non-Small Cell Lung Cancer Using Multiplex Immunofluorescence.
    Peng H; Wu X; Zhong R; Yu T; Cai X; Liu J; Wen Y; Ao Y; Chen J; Li Y; He M; Li C; Zheng H; Chen Y; Pan Z; He J; Liang W
    Front Immunol; 2021; 12():750046. PubMed ID: 34804034
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Existence of intratumoral tertiary lymphoid structures is associated with immune cells infiltration and predicts better prognosis in early-stage hepatocellular carcinoma.
    Li H; Wang J; Liu H; Lan T; Xu L; Wang G; Yuan K; Wu H
    Aging (Albany NY); 2020 Feb; 12(4):3451-3472. PubMed ID: 32087064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intratumoral Microbiota Changes with Tumor Stage and Influences the Immune Signature of Oral Squamous Cell Carcinoma.
    Pratap Singh R; Kumari N; Gupta S; Jaiswal R; Mehrotra D; Singh S; Mukherjee S; Kumar R
    Microbiol Spectr; 2023 Aug; 11(4):e0459622. PubMed ID: 37409975
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic Impact of Programmed Death-ligand 1 and Surrounding Immune Status on Stage I Lung Cancer.
    Handa Y; Tsutani Y; Shiroma N; Kai Y; Mimae T; Miyata Y; Takeshima Y; Arihiro K; Okada M
    Clin Lung Cancer; 2020 Jul; 21(4):e302-e314. PubMed ID: 32102750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures.
    Dieu-Nosjean MC; Antoine M; Danel C; Heudes D; Wislez M; Poulot V; Rabbe N; Laurans L; Tartour E; de Chaisemartin L; Lebecque S; Fridman WH; Cadranel J
    J Clin Oncol; 2008 Sep; 26(27):4410-7. PubMed ID: 18802153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic impact of the post-treatment T cell composition and spatial organization in soft tissue sarcoma patients treated with neoadjuvant hyperthermic radio(chemo)therapy.
    Rupp L; Resag A; Potkrajcic V; Warm V; Wehner R; Jöhrens K; Bösmüller H; Eckert F; Schmitz M
    Front Immunol; 2023; 14():1185197. PubMed ID: 37261361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tertiary lymphoid structure score: a promising approach to refine the TNM staging in resected non-small cell lung cancer.
    Rakaee M; Kilvaer TK; Jamaly S; Berg T; Paulsen EE; Berglund M; Richardsen E; Andersen S; Al-Saad S; Poehl M; Pezzella F; Kwiatkowski DJ; Bremnes RM; Busund LR; Donnem T
    Br J Cancer; 2021 May; 124(10):1680-1689. PubMed ID: 33723388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic implications of intratumoral CD103+ tumor-infiltrating lymphocytes in pulmonary squamous cell carcinoma.
    Koh J; Kim S; Kim MY; Go H; Jeon YK; Chung DH
    Oncotarget; 2017 Feb; 8(8):13762-13769. PubMed ID: 28099920
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peritumoral tertiary lymphoid structure and tumor stroma percentage predict the prognosis of patients with non-metastatic colorectal cancer.
    Wang Q; Shen X; An R; Bai J; Dong J; Cai H; Zhu H; Zhong W; Chen W; Liu A; Du J
    Front Immunol; 2022; 13():962056. PubMed ID: 36189233
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic value of immune cell infiltration, tertiary lymphoid structures and PD-L1 expression in Merkel cell carcinomas.
    Behr DS; Peitsch WK; Hametner C; Lasitschka F; Houben R; Schönhaar K; Michel J; Dollt C; Goebeler M; Marx A; Goerdt S; Schmieder A
    Int J Clin Exp Pathol; 2014; 7(11):7610-21. PubMed ID: 25550797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.